DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Lake Street Capital Markets Downgrades DermTech Inc. (DMTK) to Hold
April 19, 2024 7:29 AM EDTLake Street Capital Markets analyst Thomas Flaten downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Hold with a price target of $0.63.
For an analyst ratings summary and ratings history on DermTech Inc. click here. For more ratings news on DermTech Inc. click here.
Shares of DermTech Inc. closed at $0.59 yesterday.
... MoreBTIG Downgrades DermTech Inc. (DMTK) to Neutral
April 19, 2024 6:03 AM EDTBTIG analyst Sung Ji Nam downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Neutral.
The analyst comments "After the market close, DermTech announced that it has initiated a formal strategic review process. DMTK will consider all strategic options, including an acquisition, merger, reverse merger, business combination, licensing, sale of assets, or other transaction. In addition, DMTK announced it is again reducing its workforce, this time by 56%, or by ~100 employees. We spoke to the company following its... More
